TL;DR
Antifungal treatments, while crucial for combating invasive fungal infections, may paradoxically worsen sepsis outcomes by eliminating beneficial intestinal fungi. This study reveals that these fungi protect against endotoxin-induced sepsis by inhibiting a key inflammatory cell death pathway (Gasdermin D-mediated pyroptosis), suggesting a need to re-evaluate prophylactic antifungal strategies in critically ill patients.
What Problem Does This Paper Address?
Critically ill patients in intensive care units (ICUs) are at high risk of invasive fungal infections (IFIs), and prophylactic antifungal therapy (AFT) is often administered to prevent these. While AFT effectively reduces fungal infection morbidity, it hasn't consistently shown improved overall survival. This raises a critical question: could AFT, by disrupting the gut's natural microbial balance, inadvertently exacerbate other life-threatening conditions common in ICUs, such as sepsis? Sepsis, a life-threatening organ dysfunction caused by a dysregulated host response to infection, is a major cause of ICU mortality. The paper hypothesizes that AFT might aggravate sepsis, particularly endotoxin-induced sepsis, by eliminating intestinal commensal fungi, which are known to play a role in host immune responses.
Methods
The researchers employed a multi-pronged approach using murine models:
- Sepsis Models: They utilized several established sepsis models, including cecal ligation and puncture (CLP), methicillin-resistant Staphylococcus aureus (MRSA) sepsis, Salmonella typhimurium sepsis, and lipopolysaccharide (LPS)-induced endotoxic shock.
- Antifungal Treatment: Mice were pretreated with fluconazole or amphotericin B, common antifungal drugs, in their drinking water for two weeks.
- Germ-Free and Antibiotic-Treated Models: To isolate the role of the gut microbiota, experiments were conducted on germ-free mice (lacking any microbes) and mice treated with broad-spectrum antibiotics to clear gut bacteria.
- Fungal Colonization and Mannan Administration: To investigate the protective role of fungi, mice were colonized with specific fungal strains (Candida tropicalis, Candida albicans) or administered mannan, a component of the fungal cell wall.
- Molecular Analysis: Key molecular mechanisms were investigated using Western blotting to detect Gasdermin D (GSDMD) cleavage, a critical step in pyroptosis.
- Fecal Fungal Burden Quantification: Quantitative PCR (qPCR) was used to measure fungal DNA in fecal samples, serving as an indicator of intestinal fungal burden.
- Cytokine Analysis: Serum cytokine levels were measured using LEGENDplex™ assays to assess inflammatory responses.
- Histology: Lung and liver tissues were examined histologically to evaluate organ damage and immune cell infiltration.
- Genetic Knockout: Experiments were also performed on GSDMD-deficient mice to confirm its role in the observed effects.
Datasets
Not discussed in the paper. The study primarily relies on experimental data generated from animal models.
Key Insights and Ideas
- Antifungals Worsen Gram-Negative Sepsis: The most striking finding is that prophylactic antifungal treatment (fluconazole and amphotericin B) significantly worsened outcomes in models of endotoxin-induced and Salmonella typhimurium-induced sepsis, but not in MRSA (gram-positive bacteria) sepsis. This points to a specific mechanism related to gram-negative bacterial components.
- Intestinal Fungi as Protective Agents: The study strongly suggests that commensal intestinal fungi are not mere bystanders but actively protect against endotoxin-induced sepsis. Eliminating them with antifungals removes this protective shield.
- Germ-Free Mice are Unaffected: Antifungal treatment did not worsen sepsis in germ-free mice, underscoring the critical role of the gut microbiota, specifically fungi, in mediating this effect.
- Molecular Mechanism: GSDMD Inhibition: The protective effect of intestinal fungi appears to be mediated by their ability to inhibit Gasdermin D (GSDMD) cleavage in the distal small intestine. GSDMD cleavage is a key event in pyroptosis, an inflammatory form of cell death that contributes to sepsis pathology. Antifungal treatment, by removing fungi, leads to increased GSDMD cleavage and thus exacerbates sepsis.
- Fungal Components Offer Protection: Even introducing a single fungal strain or administering mannan (a fungal cell wall component) was sufficient to protect mice from endotoxin-induced sepsis, further highlighting the role of fungi and their components.
Key Results
- Reduced Survival: Fluconazole treatment led to a dramatically lower survival rate in CLP and LPS-induced sepsis models compared to controls.
- Aggravated Inflammation: Antifungal treatment increased the production of pro-inflammatory cytokines (IL-1β, TNF-α, IL-23, IL-12p70) and anti-inflammatory cytokine IL-10 in response to LPS challenge.
- Increased GSDMD Cleavage: Antifungal treatment significantly increased GSDMD cleavage in the ileum after LPS challenge.
- Protection by Fungi: Cohousing with wild hamsters (to transfer fungi) or colonizing mice with Candida species or mannan administration protected against LPS-induced sepsis.
- GSDMD Deficiency Abolishes AFT Effect: GSDMD-deficient mice treated with fluconazole did not show worsened sepsis outcomes, confirming GSDMD's central role.
Limitations and Future Work
- Translational Relevance: While the study used clinically relevant antifungal drugs and doses that resulted in serum concentrations comparable to human therapeutic levels, the findings are from murine models. Further clinical studies are needed to confirm these observations in human patients.
- Complexity of Sepsis: The authors acknowledge that sepsis is a complex syndrome with multifactorial pathogenesis. While their findings highlight a crucial aspect, other factors may also contribute to the overall outcome.
- Host Adaptation: The exact mechanism by which commensal fungi adapt the host immune system to restrain sepsis response requires further detailed research. It's unclear if it's direct fungal action or a host adaptation to the fungal presence.
- Upstream Regulators: The study identifies GSDMD cleavage as a downstream event. Future work could explore how commensal fungi regulate upstream components of GSDMD signaling, such as CASP11.
- Clinical Re-evaluation: The paper strongly advocates for re-evaluating the role of preserving intact intestinal fungi in critical patients at risk of endotoxin-induced sepsis and suggests a shift in perspective on prophylactic AFT.
Summary updated